Ropes & Gray advised ImmunoGen, while Walder Wyss advised the funds managed by Pharmakon Advisors. ImmunoGen, Inc. (Nasdaq: IMGN) announced it has entered into a term loan...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here